CL2016001447A1 - Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal. - Google Patents

Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal.

Info

Publication number
CL2016001447A1
CL2016001447A1 CL2016001447A CL2016001447A CL2016001447A1 CL 2016001447 A1 CL2016001447 A1 CL 2016001447A1 CL 2016001447 A CL2016001447 A CL 2016001447A CL 2016001447 A CL2016001447 A CL 2016001447A CL 2016001447 A1 CL2016001447 A1 CL 2016001447A1
Authority
CL
Chile
Prior art keywords
site
mediastinum
sinuses
chlorhexidine
colon
Prior art date
Application number
CL2016001447A
Other languages
English (en)
Spanish (es)
Inventor
Carolyn L Twomey
Gareth Clarke
Samuel J Zaidspiner
Original Assignee
Innovation Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Tech Inc filed Critical Innovation Tech Inc
Publication of CL2016001447A1 publication Critical patent/CL2016001447A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/15Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/00051Accessories for dressings
    • A61F13/00063Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0085Brain, e.g. brain implants; Spinal cord
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0017Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206Biguanides, e.g. chlorohexidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CL2016001447A 2013-12-12 2016-06-10 Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal. CL2016001447A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361915281P 2013-12-12 2013-12-12

Publications (1)

Publication Number Publication Date
CL2016001447A1 true CL2016001447A1 (es) 2017-04-07

Family

ID=53367098

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001447A CL2016001447A1 (es) 2013-12-12 2016-06-10 Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal.

Country Status (15)

Country Link
US (9) US9642820B2 (https=)
EP (1) EP3079681B1 (https=)
JP (2) JP2017503852A (https=)
KR (1) KR20160096678A (https=)
CN (1) CN105979940A (https=)
AU (2) AU2014361828A1 (https=)
BR (1) BR112016013199A2 (https=)
CA (1) CA2933065C (https=)
CL (1) CL2016001447A1 (https=)
IL (1) IL246087A0 (https=)
MX (1) MX388424B (https=)
PH (1) PH12016501099A1 (https=)
RU (1) RU2682642C1 (https=)
SG (2) SG11201604596RA (https=)
WO (1) WO2015089421A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
CN103347562B (zh) 2010-12-08 2016-08-10 康沃特克科技公司 伤口分泌液系统附件
PL2648795T3 (pl) 2010-12-08 2023-05-08 Convatec Technologies Inc. System do usuwania wysięków z miejsca rany
JP5965409B2 (ja) 2010-12-08 2016-08-03 コンバテック・テクノロジーズ・インコーポレイテッドConvatec Technologies Inc 創傷滲出液を評価するための統合システム
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
JP2016507663A (ja) 2012-12-20 2016-03-10 コンバテック・テクノロジーズ・インコーポレイテッドConvatec Technologies Inc 化学修飾セルロース系繊維の加工
MX388424B (es) 2013-12-12 2025-03-19 Innovation Tech Inc Materiales y metodos para controlar infecciones.
US10016375B2 (en) 2013-12-12 2018-07-10 Paul J. Rucinski Materials and methods for controlling infections
US9848604B2 (en) * 2014-07-11 2017-12-26 Medtronic Xomed, Inc. Antimicrobial wash
US20160038442A1 (en) * 2014-08-08 2016-02-11 Innovation Technologies, Inc. Materials and methods for controlling infections with negative pressure wound therapy
GB2543544A (en) 2015-10-21 2017-04-26 Brightwake Ltd Wound dressing
WO2017173069A1 (en) 2016-03-30 2017-10-05 Convatec Technologies Inc. Detecting microbial infections in wounds
WO2017212345A2 (en) 2016-03-30 2017-12-14 Synovo Gmbh Detecting microbial infection in wounds
JP6941157B2 (ja) * 2016-05-06 2021-09-29 サックシュ・コーポレーション 眼科用組成物
GB201608099D0 (en) 2016-05-09 2016-06-22 Convatec Technologies Inc Negative pressure wound dressing
ES2912094T3 (es) 2016-07-08 2022-05-24 Convatec Technologies Inc Detección de flujo de fluidos
BR112019000284A2 (pt) 2016-07-08 2019-04-16 Convatec Technologies Inc. aparelho de coleta de fluido
JP7071957B2 (ja) 2016-07-08 2022-05-19 コンバテック・テクノロジーズ・インコーポレイテッド 可撓性陰圧システム
JP2019532991A (ja) * 2016-10-26 2019-11-14 イノベーション テクノロジーズ インコーポレイテッド バイオフィルムの制御のための材料および方法
MX2020002119A (es) * 2017-08-25 2020-09-18 AZ Solutions LLC Sistema y método para el tratamiento y la irrigación de heridas.
EP3684436B1 (en) 2017-09-22 2024-11-27 Becton, Dickinson and Company 4% trisodium citrate solution for use as a catheter lock solution
WO2019084134A1 (en) * 2017-10-24 2019-05-02 Saint Anthony Biomedical, LLC COMPOSITIONS AND METHODS FOR REDUCING INFECTION IN WOUNDS AND SURGICAL SITES
US12161792B2 (en) 2017-11-16 2024-12-10 Convatec Limited Fluid collection apparatus
WO2020005785A1 (en) * 2018-06-26 2020-01-02 Innovation Technologies, Inc. Pyrogen binding composition and use of same in treatment and prevention of sepsis
EP4295869B1 (en) 2019-06-03 2026-01-28 Convatec Limited Devices to disrupt and contain pathogens
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
CN112294789B (zh) * 2020-10-15 2022-06-07 郑涛 用于防治呼吸道感染的复方制剂及其应用
WO2022106505A1 (en) * 2020-11-18 2022-05-27 Institut Curie Dimers of biguanidines and their therapeutic uses
US11722993B2 (en) * 2021-03-23 2023-08-08 Qualcomm Incorporated Techniques for configuring resources in a sidelink resource pool
US11951087B2 (en) 2021-07-27 2024-04-09 Lanny Leo Johnson Eye wash compositions and methods
US20250282811A1 (en) * 2021-10-02 2025-09-11 Desert King Chile S.A A 3-o-monodesmosidic saponins extract, stable at physiological ph, method for preparing it from a quillaja plant extract cultured with a microbial consortium, uses and such microbial consortium

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2090354A (en) * 1936-05-14 1937-08-17 Abraham E Massman Combined medicine dropper and swab
US4299221A (en) * 1979-09-28 1981-11-10 Stryker Corporation Irrigation and suction handpiece
US4704102A (en) * 1982-09-30 1987-11-03 Geneco Inc. Method of eliminating intra abdominal infections
US5002769A (en) * 1987-03-13 1991-03-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for the sustained-release of chlorhexidine
IE883722L (en) * 1988-12-14 1990-06-14 Galway Dental Technology Ltd Fluid dispenser for the treatment of a dental disorder
US4925668A (en) * 1989-01-18 1990-05-15 Becton, Dickinson And Company Anti-infective and lubricious medical articles and method for their preparation
US5002528A (en) * 1989-12-15 1991-03-26 Aubrey Palestrant Percutaneous irrigation and drainage system
US5333603A (en) * 1992-02-25 1994-08-02 Daniel Schuman Endoscope with palm rest
US6558686B1 (en) * 1995-11-08 2003-05-06 Baylor College Of Medicine Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor
JPH09301858A (ja) * 1996-05-13 1997-11-25 Senju Pharmaceut Co Ltd グルコン酸クロルヘキシジン安定化水性薬剤
US5725311A (en) 1996-07-19 1998-03-10 Sage Products, Inc. Resealable package with label peeling inhibiting means
JP3054758B2 (ja) * 1997-03-27 2000-06-19 小林製薬株式会社 外傷用組成物
US5906278A (en) 1997-10-06 1999-05-25 Sage Products, Inc. Patient bathing system
US5956794A (en) 1997-10-31 1999-09-28 Sage Products, Inc. Patient bathing system and washcloth for body cleansing
RU2166314C2 (ru) * 1999-07-06 2001-05-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Лечебно-профилактическое средство "гексикон", обладающее антибактериальным и антисептическим действием
US7066932B1 (en) * 2001-05-26 2006-06-27 Map Technologies Llc Biologically enhanced irrigants
US6964653B2 (en) * 2002-02-06 2005-11-15 Felipe Negron Multi-use hygienic cleansing device
US7066916B2 (en) 2003-05-12 2006-06-27 Sage Products, Inc. Disinfectant delivery system, and method of providing alcohol-free disinfection
RU2240821C1 (ru) * 2003-06-02 2004-11-27 Научно-исследовательский институт вакцин и сывороток им. И.И.Мечникова РАМН Способ лечения урогенитальных инфекций
IL156945A0 (en) * 2003-07-15 2004-02-08 Itzhak Tavori Device and a method for orthopedic delivery of bone reconstruction medium
MXPA06003155A (es) * 2003-09-22 2006-06-05 Innovation Technologies Inc Dispositivo y metodo de irrigacion de heridas.
WO2005084627A1 (en) 2004-03-01 2005-09-15 University Of Iowa Research Foundation Alcohol-free chlorhexidine compositions
US20080139450A1 (en) * 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
NZ564904A (en) * 2005-07-01 2010-07-30 Kane Biotech Inc Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices
US20100087788A1 (en) * 2006-10-18 2010-04-08 Joel Rosenblatt Anti-infective alcohol catheter solution with chlorhexidine treated catheter
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
GB0716605D0 (en) * 2007-08-24 2007-10-03 Univ Aston Skin antiseptics
US8696820B2 (en) * 2008-03-31 2014-04-15 Bard Access Systems, Inc. Method of removing a biofilm from a surface
US8357385B2 (en) * 2008-04-07 2013-01-22 Interface Biologics Inc. Combination therapy for the treatment of bacterial infections
KR101631335B1 (ko) * 2008-08-01 2016-06-16 온딘 인터내셔널 리미티드. Mrsa 치료용 조성물 및 방법
US8622996B2 (en) * 2008-10-27 2014-01-07 Pursuit Vascular, Inc. Method for applying antimicrobial to proximal end of catheter
RU2455037C2 (ru) * 2009-05-14 2012-07-10 Государственное образовательное учреждение высшего профессионального образования "Челябинская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ локальной иммунокоррекции инфекционно-воспалительных заболеваний урогенитального тракта женщин, вызванных микроорганизмами, передаваемыми половым путём
JP5639345B2 (ja) * 2009-05-27 2014-12-10 花王株式会社 バイオフィルム除去剤組成物
RU2404430C1 (ru) * 2009-07-27 2010-11-20 Ирина Дмитриевна Евтушенко Способ диагностики атрофии влагалища у женщин репродуктивного возраста в состоянии постовариоэктомии
JP2013508457A (ja) * 2009-10-26 2013-03-07 イノベーション テクノロジーズ インコーポレーティッド 感染を制御するための装置、方法、および組成物
US8343525B2 (en) 2009-12-22 2013-01-01 Becton, Dickinson And Company Chlorhexidine acetate antiseptic cleaning agent
DK2600869T3 (da) * 2010-08-05 2020-11-16 Helperby Therapeutics Ltd Kombination af en pyrroloquinolinforbindelse og et beta-lactam-antimikrobielt middel, mupirocin eller chlorhexidin
US8529546B2 (en) * 2010-10-21 2013-09-10 John J. Martinez Sinusal guide cannula and kit for irrigation, suction and washing
US20120150131A1 (en) 2010-12-09 2012-06-14 Teleflex Medical Incorporated Polymer for Controlling Delivery of Bioactive Agents and Method of Use
EP2750625A4 (en) * 2011-08-31 2015-08-19 Univ Columbia REDUCTION OF BIOFILMS ON MEDICAL DEVICES
US9327095B2 (en) * 2013-03-11 2016-05-03 Becton, Dickinson And Company Blood control catheter with antimicrobial needle lube
CN103211805A (zh) * 2013-04-18 2013-07-24 江苏健裕健康医疗器械有限公司 洗必泰葡萄糖酸盐复合消毒液
US9345414B1 (en) 2013-09-25 2016-05-24 Bardy Diagnostics, Inc. Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer
MX388424B (es) * 2013-12-12 2025-03-19 Innovation Tech Inc Materiales y metodos para controlar infecciones.

Also Published As

Publication number Publication date
US9931310B2 (en) 2018-04-03
CA2933065A1 (en) 2015-06-18
EP3079681A4 (en) 2017-11-22
US20150164829A1 (en) 2015-06-18
US20180055794A1 (en) 2018-03-01
US20180055793A1 (en) 2018-03-01
KR20160096678A (ko) 2016-08-16
EP3079681B1 (en) 2022-06-01
US11033517B2 (en) 2021-06-15
US9668989B2 (en) 2017-06-06
CA2933065C (en) 2021-08-24
US20190307709A1 (en) 2019-10-10
US20160279080A1 (en) 2016-09-29
US20200289435A1 (en) 2020-09-17
CN105979940A (zh) 2016-09-28
AU2014361828A1 (en) 2016-06-30
AU2018271354A1 (en) 2019-01-17
US20160271079A1 (en) 2016-09-22
PH12016501099A1 (en) 2016-07-11
AU2018271354B2 (en) 2020-05-21
US10507191B2 (en) 2019-12-17
SG11201604596RA (en) 2016-07-28
US20180221311A1 (en) 2018-08-09
RU2682642C1 (ru) 2019-03-20
JP2017503852A (ja) 2017-02-02
IL246087A0 (en) 2016-07-31
MX388424B (es) 2025-03-19
US11559503B2 (en) 2023-01-24
US9642820B2 (en) 2017-05-09
SG10201811454WA (en) 2019-01-30
US20210259996A1 (en) 2021-08-26
MX2016007679A (es) 2017-02-28
WO2015089421A1 (en) 2015-06-18
JP2019189613A (ja) 2019-10-31
US10172813B2 (en) 2019-01-08
BR112016013199A2 (pt) 2020-06-30
US10226437B2 (en) 2019-03-12
EP3079681A1 (en) 2016-10-19
US10682318B2 (en) 2020-06-16

Similar Documents

Publication Publication Date Title
CL2016001447A1 (es) Uso de una solución acuosa de clorhexidina (&lt;1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal.
BR112015007659A8 (pt) mecanismos químicos e métodos para o uso dos mesmos, especialmente na injeção de fluidos altamente viscosos
IL240283A (en) Topical veterinary compositions comprising an isoxazoline active agent, methods and uses thereof for treating or preventing a parasitic infection or infestation in a mammal
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
BR112015011036A2 (pt) derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais
BR112015024411A2 (pt) desaza-purinonas macrocíclicas para o tratamento de infeções virais
EA201591004A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
BR112015027704A2 (pt) Composto, uso do mesmo e composição farmacêutica antibacteriana
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
MX2015012342A (es) Composición farmacéutica de clorhidrato de s-cetamina.
UA115811C2 (uk) Стабільний розчин об&#39;єднаних баклофену, сорбіту і налтрексону для перорального застосування
EA201591624A1 (ru) Новые производные пиразола
BR112015027477A8 (pt) bolus, seus usos, e kit
CL2015002346A1 (es) Estra-1,3,5(10),16-tetraeno-3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
PE20160012A1 (es) Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral
CL2014003012A1 (es) Formulación en capsulas que comprende al menos un compuesto de formula (i), solubilizado; metodo de administracion de la formulacion; uso para tratar una infeccion por el virus de la hepatitis c.
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
MX377688B (es) Métodos para administrar óxido nítrico a la sangre arterial o arterializada.
UY34921A (es) Derivados de carbamato/urea
ECSP16096831A (es) Derivados de naftiridinadiona
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso
BR112015028876A2 (pt) derivados de perhidroquinoxalina